Unlock instant, AI-driven research and patent intelligence for your innovation.
Medicinal composition for treating infant asthma and preparation method and use thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and technology for infants and young children, applied in the directions of drug combination, pharmaceutical formula, drug delivery, etc., to achieve the effects of prolonging the incubation period, relieving asthma symptoms, and reducing the number of animals
Inactive Publication Date: 2010-10-13
CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF4 Cites 7 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0025] The preparation of embodiment 1 medicament oral liquid of the present invention
[0029] The above seven flavors, asarum, add water, distill and extract, collect aromatic water, and set aside; Aster add 80% ethanol, reflux extraction, filtrate recover ethanol for use; the above five flavors such as Asarum, aster herb residue and the rest of ephedra, add water to decoct three times, filter , combine the filtrate and the above-mentioned distillationmother liquor, concentrate under reduced pressure, add ethanol, leave standstill, filter, reclaim the ethanol from the filtrate, add the above-mentioned aromatic water, sorbic acid, polysorbate 80 (wherein, the consumption of sorbic acid is 0.1% of the total amount of oral liquid) %, the dosage of polysorbate 80 is 2.0% of th...
Embodiment 2
[0036] The preparation of embodiment 2 pharmaceutical capsules of the present invention
[0037] Take ephedra 52.5g, shegan 58.45g, asarum 11.55g, Tinglizi 52.5g, scutellaria baicalensis 58.45g, coltsfoot flower 58.45g, aster 58.45g. According to the method of Example 1, prepare the filtrate to recover ethanol, add double distilled liquid, mix, add starch to granulate, granulate, and prepare granules.
Embodiment 3
[0038] The preparation of embodiment 3 pharmaceutical granules of the present invention
[0041] Ephedra 217g, Shegan 347g, Asarum 130g, Tinglizi 347g, Dilong 347g, Scutellaria baicalensis 347g, Bellflower 173g, Citrus aurantii 173g, Aster 260g, Coltsfoot 260g, according to the method of Example 1, prepare the filtrate to recover ethanol, add heavy Distillate, mix, add starch to granulate, granulate, compress into tablets to obtain tablets.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a medicinal composition for treating infant asthma, which is a preparation prepared from the following raw materials in part by weight: 52.5 to 97.5 parts of ephedra herb, 58.45 to 108.55 parts of rhizoma belamcandae, 11.55 to 21.45 parts of manchurian wildginger, 52.5 to 97.5 parts of pepperweed seed, 58.45 to 108.55 parts of radix scutellariae, 58.45 to 108.55 parts of common coltsfoot flower, and 58.45 to 108.55 parts of tatarian aster root. The invention also provides a preparation method and use of the medicinal composition. The medicinal composition has the effects of relieving exterior syndrome and promoting expectoration, removing phlegm and curing asthma, mainly treats young child cough, sputum obstruction on throat, asthmatic and breath holding symptom, and the like, and is applied to infant asthma, capillary bronchitis, asthma, and the like. The medicinal composition for treating the infant asthma has the advantages of clinical revealing rate of 73.3 percent, clinical total effective rate of 96.6 percent, and obvious improvement on relieving asthma symptomsafter treatment.
Description
technical field [0001] The invention relates to a pharmaceutical composition for treating infantile asthma, which belongs to the field of medicines. Background technique [0002] Bronchial asthma is a common, refractory chronic lungdisease. Over the past ten years, the morbidity and mortality in some countries such as Britain, the United States, and Australia have all increased, and the incidence rate in my country is close to 1% (1992 years), and the incidence rate is high under the age of 12. The age of onset is less than 6 years old, and about 84.8% of patients are less than 3 years old. The incidence rate of children's asthma in Sichuan Province is 1.95%, ranking second in the country. The preliminary conclusion of the second national survey in 2001 has a great increase in the incidence rate of asthma. Recent studies have shown that allergic inflammation of the airway (AAI) and airway hyperresponsiveness (AHR) play a dominant role in the pathogenesis of asthma. In rece...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
